Clinical Trials Directory

Trials / Completed

CompletedNCT04388059

Antrum Size, Glucagon-like Peptide 1 Levels and Glycemic Control After Sleeve Gastrectomy in Morbid Obese Diabetic Adolescents

Effect of Antrum Size on Glucagon-like Peptide 1 (GLP1) Levels and Glycemic Control After Sleeve Gastrectomy in Morbid Obese Diabetic Adolescents

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
12 Years – 20 Years
Healthy volunteers
Not accepted

Summary

Childhood obesity can adversely affect every organ and often has serious consequences. Compare the effect of transection at 2cm vs at 5cm from the pylorus during laparoscopic sleeve gastrectomy on the postoperative weight loss, glucagon-like peptide 1 levels and the glycemic control in morbid obese diabetic adolescents.

Detailed description

This was a retrospective sub-analysis included 18 type 2 diabetic morbidly obese adolescents of both genders from a larger study (performed on 67 patients between December 2014 and December 2015) conducted at pediatric surgery unit, surgical department, Egypt. They were divided in 2 groups, done by 2 surgeons, group A (8 patients) the first stable line was at 2 cm from the pylorus, and group B (10 patients) at 5 cm from the pylorus.

Conditions

Interventions

TypeNameDescription
PROCEDURELaparoscopic sleeve gastrectomyLaparoscopic sleeve gastrectomy at 2 and 5 cm from the pylorus on the postoperative weight loss, GLP1 levels and the glycemic control in morbid obese diabetic adolescents.

Timeline

Start date
2014-12-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2020-05-14
Last updated
2020-05-14

Source: ClinicalTrials.gov record NCT04388059. Inclusion in this directory is not an endorsement.